High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis - Concepedia

Concepedia

Publication | Open Access

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

DOI Full Paper Access

157

Citations

16

References

2018

Year

Massimo Puoti, Graham R. Foster, Stanley Wang, David Mutimer, Edward Gane, Christophe Moreno, Ting Chang, Samuel S. Lee, Rui Marinho, Jean‐François Dufour,

Journal of Hepatology

References

	Year	Citations

Page 1